Biotech Clinuvel Pharmaceuticals now expanding UV research
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
